Tharimmune, Inc. is a biotechnology company focused on developing innovative therapies to address autoimmune diseases and other immune system-related disorders

The company leverages advanced technologies and scientific research to create targeted treatments that aim to modulate immune responses, improving patient outcomes and quality of life. Tharimmune's pipeline includes several therapeutic candidates in various stages of development, reflecting its commitment to advancing the understanding and treatment of complex immunological conditions. Through collaborations and a dedicated approach to research and development, Tharimmune aspires to make significant contributions to the field of immunotherapy.